A new drug reduces risk of psychosis relapse in patients with dementia
Pimavanserin has not received approval from the FDA, but study results are encouraging
After decades of work, an effective cytomegalovirus vaccine is on the horizon
Monoclonal antibodies reveal key vaccine structure
Alzheimer's drugs targeting amlyoid plaque may be doomed to fail
In a study of the cause of Alzheimer's, cognitive decline tracked something other than high levels of amyloid plaques
How “evolutionary medicine” helps create drugs that prevent antibiotic resistance
How do you stop a bug from becoming a superbug? Beat it at Darwin’s game
How scientists developed the most popular anesthetic used today, without totally knowing how it works
The "milk of amnesia" is relatively new, and is predated by centuries of weak attempts at pain relief
New drug addresses long overlooked "negative" symptoms of schizophrenia
A data-driven search found a compound that shows promising results in early trials
New research describes how the inflammation characteristic of multiple sclerosis affects neurons
Inflammation destroys the junctions between neurons, slowing information transfer
Yeast could soon make psilocybin cheaper than their magic mushroom cousins can
New work could even lead to psychedelic intermediates not previously available in large quantities
El caso de tres medicamentos reutilizados para los ensayos para tratar el COVID-19
¿Confundido acerca de qué drogas funcionan o no?
Drug repurposing gave remdesivir its second, third, and fourth chance
The antiviral has had a charmed life, failing multiple times but coming back again and again
Using artificial intelligence to discover new treatments for superbugs
Machine learning is pointing researchers toward molecules that are structurally different from current antibiotics
Ice Bucket Challenge donations have helped fund promising ALS clinical trials, especially for "fast progressors"
There are currently only four drugs approved to help treat amyotrophic lateral sclerosis (ALS)
A failed Alzheimer's drug stops cancer cells from shedding their coats and hiding from the immune system
A chance reading and a fortuitous overlap between Alzheimer's and multiple myeloma biology gave a failed drug new life
Astrocytes, a type of brain cell. The nuclei of individual cells are stained blue, and structural filaments within the cell are yellow.
GerryShaw on Wikimedia Commons
Researchers find four new drug candidates to tackle Huntington's disease
There is currently no approved treatment for the reversal of Huntington's disease
New research shows how protein aggregates destroy muscle cells
These findings have important implications for the treatment of myofibrillar myopathies, a set of diseases that affect the muscles
Researchers optimized a reaction involving DEAD to reduce chemical waste
The Mitsunobu reaction is key to using alcohols in organic chemistry, but it also generates considerable chemical waste
New types of drugs, called PROTACs, melt cancer-causing proteins away
Researchers from Yale and Oregon Health and Science universities have now used this approach to treat chronic myeloid leukemia cells
.jpg?auto=format&fit=max&w=3840 "tublerculosis bacteria")
We have many tools in the fight against antibiotic resistance, and we should consider not using them
New studies hold promise for treating tuberculosis — but also suggest that sometimes the best course of action in treating infections is no action
Is your gut microbiome stealing your drugs?
New research identifies how our gut microbiomes interfere with the medications we take, and offers the possibility of medicine personalized to our gut bacteria.
Scientists have discovered how to slow the process that creates drug-resistant cancer
Blocking the path of tumor evolution improves treatment outcomes